← Back to All Filings

Plexus Corp Chairman Granted 1,370 Restricted Stock Units (RSUs)

Low SignificanceNovember 3, 2025 at 4:35:02 PM EST

PLEXUS CORP

$PLXS4/ACIK: 0000785786

Subscribe to track PLXS

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Plexus Corp Chairman Granted 1,370 Restricted Stock Units (RSUs)

Company: PLEXUS CORP (PLXS) Form: 4/A | Filed: 2025-11-03 Significance: Low

Insider: FOATE DEAN A Title: Chairman of the Board | Relationship: Director

Transaction: • Type: Grant (Award) • Shares: 1,370 RSUs • Price: $0.00 • Value: $0 • Owned After: 1,370 RSUs

Key Insight: A routine, corrective filing for an equity grant to the Chairman of the Board. The shares represent a negligible 0.005% of total shares outstanding, indicating minimal dilution.

Market Context: This is an amended filing (4/A) to correct the number of RSUs previously reported. Such grants are common forms of non-cash compensation for executives and directors.

Comprehensive Analysis

SEC Filing Analysis: PLEXUS CORP (PLXS)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The Chairman of the Board, Dean A. Foate, was granted 1,370 Restricted Stock Units (RSUs) as part of a standard compensation plan. This Form 4/A amends a previous filing to correct the number of units.
  • Market Impact: The transaction is a non-cash award and has a negligible impact on the market, representing minimal potential dilution.

Company Information

FieldValue
CompanyPLEXUS CORP
Ticker SymbolPLXS
CIK0000785786
IndustryPRINTED CIRCUIT BOARDS [3672]

Insider Information

FieldValue
NameFOATE DEAN A
CIK0001223189
Title/PositionChairman of the Board
RelationshipDirector

Transaction Details

FieldValue
Form Type4/A
Transaction Date2025-02-03
Transaction CodeA (Grant)
Security TypeRestricted Stock Units
Shares Involved1370
Price Per Share$0.00
Total Value$0
Shares Owned After1370 (RSUs)
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$0
% of Market Cap0.0%
Shares Transacted1,370
% of Shares Outstanding0.005%
Post-Transaction Ownership1,370 RSUs (potential 0.005% of outstanding upon vesting)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: Plexus Corp has a market capitalization of $3.78 billion. This grant has no immediate market value and is insignificant in the context of the company's size.
  • Ownership Concentration: The grant establishes a small potential holding for the insider, representing a tiny fraction of the total shares outstanding.
  • Dilution Impact: The potential dilution from these 1,370 shares is approximately 0.005%, which is immaterial to existing shareholders.
  • Transaction Significance: The transaction is a routine equity award, a common practice for executive and director compensation. Its size relative to both market cap and shares outstanding is negligible, confirming its low significance.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: This is a standard, non-cash compensation grant that was previously disclosed and is now being corrected. It does not signal any new insider sentiment or change in company fundamentals.

Volume & Sentiment

  • Expected Volume Impact: None. This is not an open-market transaction.
  • Sentiment Indicator: Neutral. The filing is administrative and informational in nature.

Additional Context

Transaction Notes

  • Special Circumstances: This is a Form 4/A, an amendment to a prior filing from 2025-02-05, filed to correct the number of RSUs granted. The RSUs are scheduled to vest on February 3, 2026, at which point they convert to common stock.
Topics:#SECFiling#InsiderTrading#PLXS#PlexusCorp#Form4#StockGrant#RSU#ExecutiveComp#Investing

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.